Monday's Analysts' Upgrades, Downgrades
Change in Ratings
Aspen Insurance (AHL) upgraded at Goldman Sachs to buy from neutral based on valuation. See attractive risk/reward profile with shares trading at 0.87 times last reported book value.
American International Group (AIG) downgraded at Goldman to neutral from buy based on balance sheet pressures and dilutive capital raises. See lower investment income and higher general insurance accident-loss ratios. Price target cut to $45 from $59.
Commercial Metals (CMC) initiated at UBS with buy rating. Price target starts at $37 and fiscal year 2008 EPS estimates begin at $2.05.Dollar Tree (DLTR) upgraded at JPMorgan to neutral from underweight. Most of the negative catalysts have played out since the CFO left last October. DRS Technologies (DRS) downgraded at Credit Suisse from outperform to neutral with a $73.50 price target. Rumored acquisition by Finmeccanica more than 50% likely to happen, but the potential price remains unclear. El Paso (EP) upgraded at JPMorgan from neutral to overweight. Valuation call, especially as fundamentals improved in the first quarter. Imclone (IMCL) downgraded at Morgan Stanley from equal-weight to underweight with a $38 price target. Do not expect ASCO data to meet expectations. Erbitux sales estimates also cut. Markel (MKL) downgraded at Goldman Sachs to sell from neutral based on view that shares will underperform peers as investors flock to beaten down names with lower multiples. Marsh & McLennan (MMC) upgraded at Goldman Sachs to neutral from sell based on improving sentiment towards turnaround efforts. Note investors are giving management the benefit of the doubt.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV